Displaying 3401 - 3420 of 4733
FTC Challenges Grifols/Talecris Merger as Anticompetitive
FTC Staff Comment Before the Federal Energy Regulatory Commission Concerning Analysis of Horizontal Market Power under the Federal Power Act (Docket No. RM11-14-000)
FTC Conditions Irving Oil's Proposed Acquisition of ExxonMobil Assets in Maine
FTC Files Amicus Brief in U.S. Court of Appeals for the Third Circuit in K-Dur Antitrust Litigation Urging Reversal of Pay-for-Delay Ruling
International Competition Network Presents Vision for its Second Decade
FTC Staff Says Proposed Massachusetts Law Would Limit Competition and Raise Costs in Distribution of Malt Beverages
FTC Chairman Leibowitz, Commissioner Kovacic to Participate in 10th Annual International Competition Network Conference In The Hague, The Netherlands
FTC Staff Finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding B.V. Failed to Report Drug Patent Agreements as Required by Law
FTC Settlement Order Bars Texas Doctors' Group from Joint Price Negotiations
Another Dose of Competition: Accountable Care Organizations and Antitrust
FTC to Host Public Forum on Competition Issues in Standard-Setting
FTC Approves Dow Chemical Application to Amend Agreement with Huntsman Related to Union Carbide Acquisition
Dow Chemical Company, The, and Union Carbide Corporation
Dow settled antitrust concerns relating to its proposed merger with Union Carbide Corporation. Dow agreed to divest and license intellectual property necessary to the production of linear low-density polyethylene -an ingredient used in premium plastic products such as trash bags and sealable food pouches -to BP Amoco plc.
FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers' Access to Lower-Cost Generic Drugs
FTC Announces Public Workshop on Antitrust and Accountable Care Organizations
FTC Requires Hikma to Sell Two Drugs as Condition of Baxter Healthcare Acquisition
FTC Dismisses Complaint in LabCorp
Laboratory Corporation of America and Laboratory Corporation of America Holdings, In the Matter of
The FTC challenged Laboratory Corporation of America’s $57.5 million acquisition of rival clinical laboratory testing company Westcliff Medical Laboratories, Inc., alleging that the transaction would lead to higher prices and lower quality in the Southern California market for the sale of clinical laboratory testing services to physician groups. The complaint also alleges that LabCorp’s acquisition of Westcliff would leave only two significant laboratories in Southern California competing to provide critical testing services to most physician groups.The FTC also filed an action in federal court to prevent LabCorp from integrating the Westcliff assets while the case is being tried in the administrative court. The federal court denied the FTC motion for an injunction pending appeal. Staff filed an emergency motion for an injunction pending appeal with the 9th Circuit, which denied the Commission's appeal. The Commission dismissed its complaint and closed the investigation.
FTC and Georgia Attorney General Challenge Phoebe Putney Health System's Proposed Acquisition of Palmyra Park Hospital as Anticompetitive
Displaying 3401 - 3420 of 4733